Close Menu

More articles about Gene Expression Research

Researchers from the Netherlands have uncovered a new gene expression signature linked to ovarian cancer survival that is providing hints about potential pathways of importance for the disease. But authors warn that using such signatures for guiding treatment may be a ways off.

Affy aims to target downstream genomic-analysis markets with the products gained through its acquisitions of Panomics and True Materials last year, roll out new genotyping assays on its GeneTitan array platform, and consolidate its manufacturing facilities.

The activities are part of Kreatech's makeover from a biotech specializing in FISH probes and labeling kits, to a molecular diagnostics company with expertise in oncology, hematology, and constitutional disorders.

Short Reads: Feb 3, 2009

Premium

Broad Institute, Expression Analysis, Helicos BioSciences, University of Texas at Austin, Applied Biosystems, University of Georgia, ABRF, Genomatix, Illumina, Mondobiotech, 23andMe, Kapa Biosystems

New Products: Feb 3, 2009

Premium

CLC Genomics Workbench 3.0, CAMERA 1.3.2.28

Genotyping Tech Guide

Premium

Genome Technology Genotyping Tech Guide

A team of Ontario researchers has identified a six-gene signature that can help predict non-small cell lung cancer outcomes — and uncovered evidence that there may be thousands of alternative prognostic signatures for the disease.

Roche will use Response Genetics' technology to assess a HER2 expression test.

The Realm of Noncoding RNAs

Premium

Small (and not-so-small) noncoding RNAs have thrown a spanner in the works of understanding genome function. We take a look at the major questions brought about by micro-RNA, Piwi-interacting RNA, and more.

A Whole New System

Premium

Now in its ninth year, the experiment that was the Institute for Systems Biology has become an established research organization known for its focus on translational science.

Using Pathways in the Clinic

Premium

Trey Ideker says the real value of gene expression data is determining which pathways are critical to a particular disease. In his cancer studies, the pathway-based approach could become a new kind of biomarker.

In the wake of the announcement that the working draft of the human genome sequence is done, BioInform spoke with four informatics

Procrea Biosciences, a reproductive medicine company known for offering paternity testing, genetic counseling, and infertility treatment at its clinic here, is venturing into functional genomics.

Pages

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.